China News Service, October 14th. According to a report by the Russian Satellite Network on the 14th, Sergeyev, President of the Russian Academy of Sciences, said that the new coronavirus vaccine developed by the Russian "Chumakov Immunobiological Drug Research and Development Center" has carried Clinical Trials.
The test results are encouraging, and the volunteers found no adverse reactions.
Data map: At the "Gamalea" National Research Center for Epidemiology and Microbiology in Moscow, Russia, staff demonstrate the new crown vaccine.
According to reports, Sergeyev said: "The first (clinical) trials of the vaccine started in Novosibirsk a week ago. The encouraging response has been received so far, and there is actually no adverse phenomenon."
According to it, the volunteers did not even develop the so-called low-grade fever (between 37-38 degrees) after vaccination.
He added: “In the first stage of testing the safety of the vaccine, everything is normal. But then the corresponding antibody with the required titer should appear. We are waiting.
According to reports, the vaccine has been specially processed based on the new coronavirus, making it infective, but at the same time it has the ability to induce an immune response.
There have been reports that the center that developed the vaccine hopes to complete the second phase of its vaccine in November.